SDS

E6000 LV WHITE
Section 10. Stability and reactivity
Hazardous decomposition
products
Under normal conditions of storage and use, hazardous decomposition products should
not be produced.
:
Section 11. Toxicological information
Acute toxicity
tetrachloroethylene
LC50 Inhalation Vapor
Rat
20 mg/l
4 hours
LD50 Dermal
Rabbit
5000 mg/kg
-
LD50 Oral
Rat
2629 mg/kg
-
titanium dioxide
LC50 Inhalation Dusts and mists
Rat - Male,
Female
5.09 mg/l
4 hours
LD50 Dermal
Rabbit
>10000 mg/kg
-
LD50 Oral
Rat - Female
5000 mg/kg
-
Product/ingredient name
Result
Species
Dose
Exposure
Carcinogenicity
Not available.
Conclusion/Summary
:
Mutagenicity
Not available.
Irritation/Corrosion
tetrachloroethylene
Eyes - Mild irritant
Rabbit
-
24 hours 500
milligrams
-
Eyes - Mild irritant
Rabbit
-
162
milligrams
-
Skin - Mild irritant
Rabbit
-
24 hours 500
milligrams
-
Skin - Severe irritant
Rabbit
-
24 hours 810
milligrams
-
Benzene, ethenyl-, polymer
with 1,3-butadiene
Eyes - Mild irritant
Rabbit
-
24 hours 500
milligrams
-
titanium dioxide
Skin - Mild irritant
Human
-
72 hours 300
Micrograms
Intermittent
-
Product/ingredient name
Result
Score
Exposure
Observation
Sensitization
titanium dioxide
skin
Mouse
Not sensitizing
Product/ingredient name
Route of
exposure
Species
Result
Species
Information on toxicological effects
Classification
The International Agency for Research on Cancer (IARC) Monograph No. 93 reports there is sufficient evidence in
experimental animals exposed to titanium dioxide but inadequate evidence for carcinogenicity in humans. Human
studies do not suggest an association between occupational exposure to titanium dioxide dust and an increased risk of
cancer. The IARC summary concludes, "that no significant exposure to titanium dioxide is thought to occur during the
use of products in which titanium dioxide is bound to other materials, such as paint".
Date of issue/Date of revision
:
8/11/2020
Version
:
1.05
7/13